Literature DB >> 32216890

In reply.

Sarah M Bagley1, Ziming Xuan2, Michael Silverstein3, Scott E Hadland4, Alexander Y Walley1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32216890      PMCID： PMC7984423          DOI： 10.1016/j.annemergmed.2019.12.016

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  5 in total

1.  Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014.

Authors:  Avik Chatterjee; Marc R Larochelle; Ziming Xuan; Na Wang; Dana Bernson; Michael Silverstein; Scott E Hadland; Thomas Land; Jeffrey H Samet; Alexander Y Walley; Sarah M Bagley
Journal:  Drug Alcohol Depend       Date:  2018-10-25       Impact factor: 4.492

2.  Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder.

Authors:  Andrew A Herring; Cody W Schultz; Elaine Yang; Mark K Greenwald
Journal:  Am J Emerg Med       Date:  2019-05-29       Impact factor: 2.469

3.  Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.

Authors:  Sarah M Bagley; Marc R Larochelle; Ziming Xuan; Na Wang; Aneesh Patel; Dana Bernson; Michael Silverstein; Scott E Hadland; Thomas Land; Jeffrey H Samet; Alexander Y Walley
Journal:  Ann Emerg Med       Date:  2019-10-04       Impact factor: 5.721

4.  Comparison of Post-Cesarean Section Opioid Analgesic Requirements in Women With Opioid Use Disorder Treated With Methadone or Buprenorphine.

Authors:  Annmarie L Vilkins; Sarah M Bagley; Kristen A Hahn; Florencia Rojas-Miguez; Elisha M Wachman; Kelley Saia; Daniel P Alford
Journal:  J Addict Med       Date:  2017 Sep/Oct       Impact factor: 3.702

5.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.